PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsPiperonyl butoxide
Piperonyl butoxide
Rid Mousse (piperonyl butoxide) is a small molecule pharmaceutical. Piperonyl butoxide was first approved as Rid mousse on 2000-03-07. It is used to treat lice infestations and scabies in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Piperonyl butoxide
+
Pyrethrins
Tradename
Company
Number
Date
Products
RID MOUSSEBayerN-021043 DISCN2000-03-07
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
abc lice killingC2002632024-01-31
best choice lice killingOTC monograph final2017-02-14
best choice lice treatmentC2002632023-12-09
care one lice killingOTC monograph final2018-02-22
careone complete kit liceOTC monograph final2019-04-26
complete lice treatment kitOTC monograph final2012-06-04
cvs 3 step lice solutionC2002632023-12-08
cvs health lice killingOTC monograph final2020-11-16
discount drug mart lice killingC2002632023-12-07
discount lice treatmentC2002632023-12-12
Show 53 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
lice infestations—D010373B85.2
scabies—D012532B86
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
11 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MalariaD008288EFO_0001068B54————1111
AnemiaD000740HP_0001903D64.9————33
Falciparum malariaD016778EFO_0007444B50————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePiperonyl butoxide
INN—
Description
Piperonyl butoxide is a member of benzodioxoles. It has a role as a pesticide synergist.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2
Identifiers
PDB—
CAS-ID51-03-6
RxCUI—
ChEMBL IDCHEMBL1201131
ChEBI ID32687
PubChem CID5794
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Piperonyl butoxide
+
Pyrethrins
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 2,167 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
249 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use